ArticlePDF Available

Neuroanatomical correlates of behavioural phenotypes in behavioural variant of frontotemporal dementia

Authors:
  • ASST Spedali Civili

Abstract and Figures

Behavioural variant of frontotemporal dementia (bvFTD) frequently presents complex behavioural changes, that rarely occur in isolation. Targeting behavioural phenotypes instead of single behavioural symptoms may potentially provide a disease model in which to investigate brain substrates of behavioural abnormalities. To identify behavioural phenotypes and to assess the associated brain correlates in a cohort of patients with bvFTD. Two hundred and seven consecutive individuals fulfilling clinical criteria for bvFTD were enrolled. Each participant's caregiver completed frontal behavioural inventory on 24 key behavioural disturbances. Confirmatory factor analysis (CFA) models were applied, and behavioural phenotypes identified. For each phenotype, a score was derived based on the "best" CFA model (Bifactor CFA). One hundred two participants underwent SPECT scan. A regression analysis between scores for each factor and regional cerebral blood flow was carried out (P<0.001). One "general" behavioural phenotype and four factors were identified, that were termed "disinhibited", "apathetic", "aggressive", and "language" phenotypes. The most robust brain correlate was identified for "disinhibited" phenotype, in the region of the anterior cingulated and anterior temporal cortex, bilaterally, and for apathetic phenotype in the left dorsolateral frontal cortex. As expected, language phenotype correlated with greater hypoperfusion in the left frontotemporal lobes. No significant correlation between aggressive phenotype and regional cerebral blood flow was found. Moreover, the "general" behavioural severity was associated with greater damage in the right frontal lobe. Behavioural phenotypes are associated with specific brain damage in bvFTD, involving distinct cerebral networks.
Content may be subject to copyright.
Behavioural
Brain
Research
235 (2012) 124–
129
Contents
lists
available
at
SciVerse
ScienceDirect
Behavioural
Brain
Research
j
ourna
l
ho
me
pa
ge:
www.elsevier.com/locate/bbr
Research
report
Neuroanatomical
correlates
of
behavioural
phenotypes
in
behavioural
variant
of
frontotemporal
dementia
B.
Borronia,,
M.
Grassib,
E.
Premia,
S.
Gazzinaa,
A.
Albericia,
M.
Cosseddua,
B.
Pagherac,
A.
Padovania
aCenter
for
Aging
Brain
and
Dementia,
Department
of
Neurology,
University
of
Brescia,
Brescia,
Italy
bDepartment
of
Health
Sciences,
Section
of
Medical
Statistics
&
Epidemiology,
University
of
Pavia,
Pavia,
Italy
cNuclear
Medicine
Unit,
University
of
Brescia,
Brescia,
Italy
h
i
g
h
l
i
g
h
t
s
Confirmatory
factor
analysis
identified
4
behavioural
phenotypes
in
FTD
sample.
Disinhibition
correlates
with
in
anterior
cingulate
and
anterior
temporal
gyri.
Apathy
correlates
in
the
left
dorsolateral
cortex.
Language
correlates
with
left
frontotemporal
lobes.
a
r
t
i
c
l
e
i
n
f
o
Article
history:
Received
4
June
2012
Received
in
revised
form
28
July
2012
Accepted
2
August
2012
Available online 10 August 2012
Keywords:
Frontotemporal
dementia
Behaviour
SPECT
Confirmatory
factor
analysis
a
b
s
t
r
a
c
t
Background:
Behavioural
variant
of
frontotemporal
dementia
(bvFTD)
frequently
presents
complex
behavioural
changes,
that
rarely
occur
in
isolation.
Targeting
behavioural
phenotypes
instead
of
single
behavioural
symptoms
may
potentially
provide
a
disease
model
in
which
to
investigate
brain
substrates
of
behavioural
abnormalities.
Objective:
To
identify
behavioural
phenotypes
and
to
assess
the
associated
brain
correlates
in
a
cohort
of
patients
with
bvFTD.
Methods:
Two
hundred
and
seven
consecutive
individuals
fulfilling
clinical
criteria
for
bvFTD
were
enrolled.
Each
participant’s
caregiver
completed
frontal
behavioural
inventory
on
24
key
behavioural
disturbances.
Confirmatory
factor
analysis
(CFA)
models
were
applied,
and
behavioural
phenotypes
iden-
tified.
For
each
phenotype,
a
score
was
derived
based
on
the
“best”
CFA
model
(Bifactor
CFA).
One
hundred
two
participants
underwent
SPECT
scan.
A
regression
analysis
between
scores
for
each
factor
and
regional
cerebral
blood
flow
was
carried
out
(P
<
0.001).
Results:
One
“general”
behavioural
phenotype
and
four
factors
were
identified,
that
were
termed
“dis-
inhibited”,
“apathetic”,
“aggressive”,
and
“language”
phenotypes.
The
most
robust
brain
correlate
was
identified
for
“disinhibited”
phenotype,
in
the
region
of
the
anterior
cingulated
and
anterior
temporal
cortex,
bilaterally,
and
for
apathetic
phenotype
in
the
left
dorsolateral
frontal
cortex.
As
expected,
lan-
guage
phenotype
correlated
with
greater
hypoperfusion
in
the
left
frontotemporal
lobes.
No
significant
correlation
between
aggressive
phenotype
and
regional
cerebral
blood
flow
was
found.
Moreover,
the
“general”
behavioural
severity
was
associated
with
greater
damage
in
the
right
frontal
lobe.
Conclusions:
Behavioural
phenotypes
are
associated
with
specific
brain
damage
in
bvFTD,
involving
dis-
tinct
cerebral
networks.
© 2012 Elsevier B.V. All rights reserved.
1.
Introduction
The
behavioural
variant
of
frontotemporal
dementia
(bvFTD)
is
one
of
the
most
frequent
causes
of
young-onset
dementia
that
manifests
with
progressive
behavioural
abnormalities,
personality
Corresponding
author
at:
Clinica
Neurologica,
Università
degli
Studi
di
Brescia,
Pza
Spedali
Civili,
1
25100
Brescia,
Italy.
Tel.:
+39
0303995632;
fax:
+39
0303995027.
E-mail
address:
bborroni@inwind.it
(B.
Borroni).
changes
and
social
dysfunction.
While
bvFTD
is
considered
a
single
entity,
there
is
considerable
variability
in
its
clinical
presentation,
and
either
apathetic
or
disinhibited
behaviours
may
be
frequently
recognised
[1–3].
Furthermore,
bvFTD
can
exhibit
changes
in
lan-
guage
[4],
the
extend
of
these
varying
between
subjects
[5].
Behavioural
disturbances
occur
in
concert
with
focal
neurode-
generation
of
frontal
and
temporal
lobes
that
can
be
quantified
with
modern
structural
and
functional
imaging
methods.
From
a
neurobiological
perspective,
bvFTD
therefore
presents
an
opportu-
nity
to
assess
the
critical
brain
substrates
that
lead
to
personality
changes.
0166-4328/$
see
front
matter ©
2012 Elsevier B.V. All rights reserved.
http://dx.doi.org/10.1016/j.bbr.2012.08.003
B.
Borroni
et
al.
/
Behavioural
Brain
Research
235 (2012) 124–
129 125
Specific
standardised
behavioural
scales,
usually
assessed
by
carer-based
questionnaires,
have
been
developed.
In
the
case
of
bvFTD,
frontal
behavioural
inventory
(FBI)
is
one
of
the
most
help-
ful
assessments
to
detect
the
pattern
and
severity
of
behavioural
abnormalities
[6,7].
A
number
of
studies
have
investigated
the
neural
correlates
of
behavioural
symptoms
in
bvFTD,
even
though
these
rarely
present
in
isolation
[3,8].
Since
bvFTD
is
associated
with
multi-
ple
behavioural
abnormalities,
it
has
been
hard
to
conclude
that
the
relationship
between
a
single
behavioural
feature
and
the
identified
brain
damage
is
unique.
As
standardised
questionnaires
include
overlapping
behavioural
disturbances,
the
analysis
of
neu-
ral
correlates
of
undergoing
behavioural
clusters
should
be
assessed
to
overcome
potential
biases
and
to
further
clarify
whether
distinct
neural
networks
are
selectively
involved.
Thus,
the
goals
of
the
present
study
conducted
in
a
large
cohort
of
bvFTD
patients
were:
(a)
to
carefully
characterize
behavioural
disturbances;
(b)
to
identify
consistent
behavioural
phenotypes
(by
using
FBI)
as
the
results
of
confirmatory
factor
analysis
mod-
elling
approaches;
(c)
to
find
out
the
functional
SPECT
correlates
of
behavioural
severity
in
bvFTD;
and
(d)
to
investigate
functional
brain
correlates
of
the
identified
behavioural
phenotypes,
using
statistical
parametric
mapping
on
SPECT
scans.
We
hypothesized
that
the
single
behavioural
disturbances
might
be
clustered
into
behavioural
phenotypes,
and
these
latter
would
correlate
with
distinct
profiles
of
brain
hypoperfusion.
2.
Methods
2.1.
Subjects
Patients
attending
the
tertiary
cognitive
disorders
clinic
at
Neurology
Depart-
ment,
University
of
Brescia,
Italy,
with
clinical
diagnoses
of
bvFTD
according
to
current
consensus
criteria
[9,10]
entered
the
study.
The
diagnosis
was
supported
by
detailed
neuropsychological
testing,
as
previously
reported
[11],
and
careful
behavioural
assessment
with
patient’s
carer.
For
each
patient,
a
structural
brain
MRI
excluded
major
causes
of
cerebrovascular
disease
and
white
matter
lesions.
bvFTD
patients
underwent
SPECT
imaging
on
the
same
scanner
for
studying
cere-
bral
blood
flow
perfusion.
Patients
with
potentially
confounding
neurological
and
psychiatric
disorders,
a
past
history
of
alcohol
abuse,
psychosis,
or
major
depres-
sion,
were
excluded
from
the
study.
The
use
of
medication
that
could
interfere
with
behavioural
disturbances
and
the
absence
of
informant
proxy
carer
were
considered
as
further
exclusion
criteria.
The
study
was
conducted
in
accordance
with
the
Declaration
of
Helsinki
and
ethics
approval
was
obtained
from
the
Ethics
Committee
of
the
Brescia
Hospital,
Italy.
2.2.
Assessment
of
behavioural
disturbances
Behavioural
disturbances
were
assessed
by
FBI
[6],
which
has
been
recently
vali-
dated
for
Italian
language
[7].
In
the
present
work,
we
used
the
latter
version.
The
FBI,
a
24-point
behavioural
assessment
tool,
was
completed
by
a
caregiver
respondent
for
each
participant
[12].
In
this
scale,
12
items
assess
negative
behaviours
(apathy,
aspontaneity,
indifference,
inflexibility,
personal
neglect,
disorganisation,
inatten-
tion,
loss
of
insight,
logopenia,
verbal
apraxia,
semantic
deficit,
alien
hand),
and
12
items
assess
positive
behaviours
(perseverations/obsessions,
irritability,
excessive
jocularity,
social
inappropriateness,
impulsivity,
restlessness,
aggression,
hyperoral-
ity,
hypersexuality,
utilisation
behaviour,
and
incontinence).
Some
of
the
negative
items
are
aimed
at
language
and
motor
behaviours.
For
the
purposes
of
this
study,
the
caregiver
respondent
was
a
first-degree
rela-
tive
with
excellent
personal
knowledge
of
the
participant.
The
respondent
was
asked
to
rate
each
item,
and
a
score
from
0
(absence)
to
3
(highly
present)
was
assigned.
2.3.
Statistical
analysis
(CFA)
Confirmatory
factor
analysis
(CFA)
modelling
was
used
to
determine
the
num-
ber
and
the
behavioural
phenotypes
(dimensions)
underling
the
FBI
instrument.
As
the
FBI
items
were
developed
and
standardised
with
reference
to
Kertesz
et
al.
[6],
CFA
was
carried
out
in
order
to
build
up
a
model
that
was
clinically
meaningful
and
comparable
to
the
original
one,
and
satisfying
the
goodness
of
fitting
index
require-
ment.
We
performed
three
CFA
models
with
different
dimensions
across
different
model
classes,
as
follows
[13,14]:
Fig.
1.
Path
diagram
of
the
fitted
confirmatory
factor
analysis
(CFA)
models.
Panel
A.
Correlated
CFA
models;
Panel
B.
Hierarchical
CFA
models;
Panel
C.
Bifactor
CFA
models.
See
Section
2
for
details.
(a)
Correlated
CFA
models
(Fig.
1a)
with
one
to
four
dimensions
extracted
by
a
prelim-
inary
exploratory
factor
analysis
(EFA)
with
oblique
rotation;
we
hypothesized
that
unidimensionality
(one
dimension)
of
the
original
FBI
instrument
was
not
adequate
for
representing
the
behavioural
construct,
but
different
highly
related
behavioural
phenotypes
might
be
the
“true”
dimension.
(b)
Hierarchical
CFA
models
(Fig.
1b)
with
two
to
four
first-order
dimensions
and
one
second-order
dimension
underling
these
first-order
behavioural
phenotypes;
we
hypothesized
an
overall
behavioural
factor,
as
the
original
FBI
instrument,
and
this
factor
was
comprised
by
at
least
four
highly
related
specific
behavioural
phenotypes
that
account
for
the
communality
of
the
items.
(c)
Bifactor
CFA
models
(Fig.
1c)
with
one
general
factor
that
account
for
the
commu-
nality
of
the
items,
and
two
to
four
factors
that
account
for
the
unique
influence
of
the
specific
behavioural
phenotypes;
we
hypothesized
that
this
general
fac-
tor
was
the
focal
interest
of
the
original
FBI
instrument,
and
the
relations
among
the
general
and
specific
behavioural
phenotypes
were
assumed
to
be
orthogo-
nal
(non-correlated),
as
these
phenotypes
were
related
to
the
item
contribution
that
was
over
and
above
the
general
factor.
The
number
of
dimensions
and
the
item
loading
structure
of
EFA
with
oblique
rotation
(Oblim
method)
was
conducted
on
the
polychoric
correlation
matrix
to
adjust
for
the
ordinal
nature
of
the
FBI
items.
Four
classical
criteria
from
EFA
were
used:
(1)
eigenvalue
rule
(i.e.,
number
of
factors
with
eigenvalue
>1);
(2)
scree
plot
(i.e.,
number
of
factors
before
the
break
in
the
scree
plot);
(3)
Horn’s
paral-
lel
analysis
(i.e.,
number
of
factors
with
eigenvalue
>average
random
eigenvalues);
(4)
factor
loading
rule
(i.e.,
item-factor
correlations
>0.32
suggested
for
behavioural
phenotypes
interpretation).
Parameters
of
CFA
models
were
obtained
by
maxi-
mum
likelihood
estimation
(MLE),
and
several
goodness-of-fit
criteria
were
used
for
model
selection
(see
legend
of
Table
2).
Factor
scores
of
the
selected
(best)
CFA
model
for
each
subject
were
computed
summing
the
original
FBI
items
per
factor
weights
derived
by
BLUP
(“Best
Linear
Unbiased
Predictor”)
method.
EFA/CFA
mod-
els
were
processed
with
R
software
(version
2.13.2
for
Windows),
and
full
details
of
the
EFA/CFA
approaches
can
be
found
in
several
references
[15].
126 B.
Borroni
et
al.
/
Behavioural
Brain
Research
235 (2012) 124–
129
2.4.
99mTc-bicisate
(ECD)
SPECT
acquisition
protocol
and
image
analysis
Patients
were
administered
an
intravenous
injection
of
1110
MBq
of
99mTc-
bicisate
(ECD)
(Neurolite,
Lantheus
Medical
Imaging)
in
a
rest
condition,
lying
supine
in
a
quiet,
dimly
lit
room.
All
individuals
were
imaged
using
a
dual-head
rotating
gamma
camera
(GE
Millenium
VG)
fitted
with
a
low-energy,
high-resolution
col-
limator,
30
min
after
intravenous
injection
of
99mTc-bicisate
(ECD).
A
128
×
128
pixel
matrix
was
used
for
images
acquisition
with
120
views
over
a
360orbit
(in
3step)
with
a
pixel
size
of
4.02
mm,
in
27
min
or
more
to
collect
at
least
5
×
106
total
counts.
Images
reconstruction
were
performed
by
a
filtered
back
projection
and
three-dimensionally
smoothed
with
a
Butterworth
filter
(cut
off
0.5
cycles/cm,
order
15).
The
reconstructed
images
were
corrected
for
gamma
ray
attenuation
using
the
Chang
method
(attenuation
coefficient:
0.11
cm1).
Statistical
Parametric
Mapping
(SPM8,
Welcome
Department
of
Cognitive
Neurology,
University
College,
London),
and
Matlab
7.1
(Mathworks
Inc.,
Sherborn,
MA)
were
used
for
images
pre-processing.
Images
were
spatially
normalised
to
a
reference
stereotactic
tem-
plate
(Montreal
Neurological
Institute,
MNI)
and
smoothed
by
a
Gaussian
kernel
of
8
mm
×8
mm
×8
mm
FWHM.
Regression
analysis
between
factor
scores
of
the
selected
CFA
and
regional
cerebral
blood
flow
was
carried
out
with
age,
gender
and
all
the
others
cluster
scores
considered
as
nuisance
variables.
Findings
meeting
a
height
threshold
of
P
<
0.005
uncorrected
were
considered
significant.
The
extension
threshold
was
set
at
25
voxels.
3.
Results
3.1.
Subjects
Two-hundred
and
seven
patients
(mean
age
66.5
±
7.4
years;
44.5%
females;
age
at
onset
63.7
±
7.4
years)
fulfilling
inclusion
and
exclusion
criteria
were
considered
in
the
present
study
(see
Table
1),
and
FBI
was
carefully
administered
to
the
proxy
carer.
As
shown
in
Fig.
2,
apathy
was
the
most
common
behavioural
disorder,
present
in
68.6%
of
patients,
followed
by
negative
symptoms
such
as
inattention,
aspontaneity,
and
disorganisation.
The
less
common
were
hypersexuality
(7.7%)
and
utilisation
behaviour
(11.6%).
3.2.
Behavioural
phenotypes
EFA
identified
four
factors
with
eigenvalues
9.44
to
1.55
>
1,
that
explained
almost
the
65.2%
and
94.4%
of
observed
total
variance,
and
of
the
observed
inter-item
correlations
matrix,
respectively;
the
Scree
plot
and
Parallel
Analysis
also
pointed
out
three
or
four
factors.
Thus,
the
Oblim
oblique
rotation
was
performed
on
two,
three
and
four
factors,
and
appearing
factor
structure
were
tested
with
CFA
modelling.
As
shown
in
Table
2,
the
best
CFA
fitting,
repre-
sented
by
the
lowest
AIC
and
BIC
scores,
and
adequate
SRMR
index,
was
the
bifactor
model
with
1
general
factor
and
4
specific
factors.
As
shown
in
Fig.
3,
according
to
bCFA
output,
a
general
behavioural
phenotype
(named
g
=
“overall
behavioural
severity”),
and
over
and
above
this
general
construct,
four
specific
behavioural
phenotypes
Table
1
Demographic
and
clinical
characteristics
of
FTLD
patients.
Variable
bvFTD
(all)
bvFTD
with
SPECT
Pa
N
207
102
Age
at
evaluation,
years 66.47
±
7.39
65.14
±
7.31
0.14
Gender,
males% 55.6%
(115)
52%(53)
0.55b
Age
at
onset,
years
63.66
±
7.45
62.7
±
7.25
0.29
Education,
years 7.43
±
3.69
7.34
±
3.38
0.83
FH,
%
42.4%
(84)
39.2%
(40)
0.62b
MMSE
21.56
±
6.34
22.16
±
5.38
0.42
FTD-modified
CDR
5.79
±
4.46
4.90
±
3.55
0.09
NPI 17.05
±
12.44
17.55
±
12.34
0.74
FBI-A
10.47
±
7.70
10.40
±
7.00
0.94
FBI-B 5.74
±
5.83
5.95
±
5.94
0.77
FBI-AB
16.23
±
12.01
16.35
±
11.58
0.93
bvFTD:
behavioural
variant
frontotemporal
dementia;
FH:
family
history;
MMSE:
mini-mental
state
examination;
FTD-modified
CDR:
frontotemporal
dementia-
modified
clinical
dementia
rating
scale;
NPI:
neuropsychiatry
inventory;
FBI:
frontal
behavioural
inventory.
Number
of
subjects
between
brackets.
at-test,
otherwise
specified.
bChi-Square
test.
were
identified.
The
first
(9
items)
was
determined
by
lack
of
judg-
ment,
personal
neglect,
perseverations,
hyperorality,
utilisation
behaviours,
hoarding,
euphoria,
and
social
inappropriateness,
thus
being
termed
f1
=
“disinhibited
phenotype”,
the
second
(2
items)
by
apathy
and
aspontaneity,
thus
being
named
f2
=
“apathetic
phenotype”;
the
third
(3
items)
by
inflexibility,
irritability
and
aggressiveness,
and
named
f3
=
“aggressive
phenotype”,
the
latter
(4
items)
by
logopenia,
aphasia,
semantic
dementia
and
alien
limb,
and
then
called
f4
=
“language
phenotype”.
Seven
items
had
not
any
specific
factor,
and
two
items
(hypersexuality
and
alien
hand)
were
not
related
to
the
general
factor.
A
score
of
each
behavioural
phenotype
(see
method
section,
sta-
tistical
analysis)
for
each
patient
was
computed;
score
correlations
are
appropriate
with
the
bifactor
model:
g
correlation
with
f1–f4
ranged
from
0.03
to
0.13.
g
and
f1–f4
high
scores
indicate
high
dis-
turbance
behavioural,
and
vice
versa.
The
measurement
reliability
(omega
index)
of
the
selected
bifactor
model
was
of
0.91.
3.3.
Brain
correlates
of
behavioural
severity
and
behavioural
phenotypes
Demographic
and
clinical
characteristics
of
this
subgroup
were
comparable
to
those
of
the
all
bvFTD
group
(see
Table
1).
A
regres-
sion
analysis
of
g
and
each
f1–f4
phenotype
scores
with
rCBF
was
carried
out.
One
hundred
two
bvFTD
patients
underwent
SPECT
scan
and
were
considered
for
further
analysis.
Fig.
2.
Behavioural
disturbances
in
bvFTD
according
to
frontal
behavioural
inventory
scale.
B.
Borroni
et
al.
/
Behavioural
Brain
Research
235 (2012) 124–
129 127
Table
2
Goodness-of-fit
indices
of
the
different
confirmatory
factor
analysis
(CFA)
models.
Model
X2
df
AIC
BIC
GFI
CFI
RMSEA
SRMR
CFA1
1306
252
801.5
117.1
0.722
0.588
0.1215
0.102
cCFA2 1109 253
602.8
319.5
0.753
0.665
0.1093
0.107
cCFA3 1046
252
541.9
376.8
0.764
0.689
0.1055
0.128
cCFA4
851.3
247
357.3
543.2
0.799
0.764
0.0930
0.117
bCFA2
816.7
228
360.7
470.5
0.806
0.770
0.0955
0.073
bCFA3
781
228
325.0
506.1
0.812
0.784
0.0926
0.073
bCFA4
670.6
228
214.6
616.6
0.835
0.827
0.0828
0.072
hCFA2 1084 250 583.7
327.7
0.754
0.674
0.1088
0.092
hCFA3 1015 249
517.4
390.3
0.769
0.700
0.1043
0.093
hCFA4 917.7
248
421.7
482.3
0.787
0.738
0.0977
0.094
X2:
model
log-likelihood
chi-square
statistic;
df:
model
degree
of
freedom
(df
=
number
of
observations
number
of
model
parameters);
AIC:
Akaike’s
information
criterion
(AIC
=
2
×
model
log-likelihood
+
2
×
number
of
model
parameters);
BIC:
Bayesian
information
criterion
(BIC
=
2
×
model
log-likelihood
+
log(n)
×
number
of
model
param-
eters),
GFI:
goodness
of
fit
index
(GFI
is
an
estimate
of
the
proportion
of
the
total
model
“variance”
that
is
free
of
“error”
variance);
CFI:
comparative
fit
index
(CFI
estimate
the
difference
of
the
fitted
model
and
a
hypothetical
(null)
model
of
zero-association);
RMSEA:
root-mean-square
error
of
approximation
(RMSEA
is
based
on
the
difference
between
the
fitted
model
and
a
hypothetical
“true”
model);
SRMR:
standardised
root-mean-square
residual
(SRMR
is
based
on
the
differences
between
observed
and
model
values
of
the
correlation
matrix).
The
recommended
criteria
for
good
fit
were
offered
by:
minimum
AIC
or
BIC;
GFI
>
0.90;
CFI
>
0.95;
RMSEA
<
0.06;
SRMR
<
0.08
[25].
As
shown
in
Fig.
4
and
Table
3,
disinhibited
phenotype
was
asso-
ciated
with
significant
greater
hypoperfusion
in
anterior
cingulate
cortex,
orbitofrontal
cortex
and
right
anterior
temporal
lobe.
Apa-
thetic
phenotype
was
related
to
greater
hypoperfusion
in
the
left
dorsolateral
frontal
cortex
and
anterior
cingulate
cortex,
bilaterally.
As
expected,
language
phenotype
correlated
with
greater
hypop-
erfusion
in
the
left
frontotemporal
lobes.
No
significant
correlation
between
aggressive
phenotype
and
rCBF
was
found.
Fig.
3.
Path
diagram
of
the
selected
(best)
bifactor
model
with
1
general
behavioural
phenotype
r
(g)
and
4
specific
behavioural
phenotypes
(f1–f4);
g
and
f1–f4
are
assumed
orthogonal
(non-correlated),
as
the
f1–f4
are
related
to
the
residual
con-
tribution
that
is
over
and
above
g.
The
inverse
correlation
between
each
phenotype
and
rCBF
did
not
show
any
significant
voxel
above
the
pre-established
statistical
threshold.
Significant
negative
correlation
was
observed
between
the
g
score,
i.e.
a
measure
of
behavioural
severity,
and
rCBF
in
right
infe-
rior
frontal
gyrus
(see
Fig.
4
and
Table
3).
The
same
pattern
was
observed
when
regression
analysis
between
total
FBI
score
and
rCBF
was
carried
out
(data
not
shown).
4.
Discussion
The
bvFTD
is
traditionally
considered
a
unitary
disease,
but
a
wide
range
of
clinical
presentations
has
been
recognised.
Accord-
ingly,
either
selective
damage
of
frontal
lobes
or
predominant
involvement
of
temporal
regions
has
been
described
in
bvFTD
[15].
In
the
present
work,
we
have
carefully
characterised
the
behavioural
disturbances
and
how
these
are
grouped
by
using
FBI
questionnaire.
The
spectrum
of
behavioural
abnormalities
was
large
and
heterogeneous,
and
consistent
with
previous
studies,
the
most
common
behaviour
was
apathy,
occurring
in
over
60%
of
subjects
[15–17].
However,
specific
phenotypes
were
iden-
tified,
namely
apathetic,
disinhibited,
aggressive
and
language
behaviours,
as
the
results
of
clustering
of
single
behavioural
symp-
toms.
Different
confirmatory
factor
analysis
models
have
been
applied
to
reach
these
results,
and
the
best
fitting
model
suggested
that
the
score
of
overall
behavioural
disturbances
(i.e.
g-score)
is
consistent
with
FBI
A
plus
FBI
B
scores,
while
subgrouping
FBI
A
and
FBI
B
as
currently
used
(i.e.,
positive
and
negative
symptoms)
seems
to
not
well
describe
the
different
behavioural
phenotypes,
these
latter
clustering
independently
from
the
two
subscales.
Furthermore,
by
functional
neuroimaging,
we
reported
that
right
frontal
lobe
was
correlated
to
g-score,
thus
suggesting
that
behavioural
severity
in
bvFTD
is
related
to
hypoperfusion
of
this
hemisphere.
In
addition,
three
out
of
four
behavioural
clusters
were
associated
with
selective
hypoperfusion
in
specific
brain
regions,
independent
of
the
effect
of
other
behaviours.
Disinhibited
phe-
notype
was
associated
with
significant
greater
hypoperfusion
in
anterior
cingulate
cortex,
left
orbitofrontal
cortex
and
right
anterior
temporal
lobe,
while
apathetic
phenotype
was
related
to
greater
hypoperfusion
in
the
left
dorsolateral
frontal
cortex
and
anterior
cingulate
cortex.
As
expected,
language
phenotype
correlated
with
greater
hypoperfusion
in
the
left
frontotemporal
lobes.
In
this
phe-
notype,
beyond
aphasia,
the
unexpected
alien
hand
symptom
was
observed;
however,
only
a
few
patients
scored
positively
to
this
FBI
item.
128 B.
Borroni
et
al.
/
Behavioural
Brain
Research
235 (2012) 124–
129
Fig.
4.
Results
of
linear
regression
analysis
between
rCBF
and
behavioural
phenotypes,
i.e.
disinhibited
(a),
apathetic
(b),
language
(c),
and
total
behavioural
score
(d)
superimposed
on
a
3D
brain
template.
A
=
anterior
view;
I
=
inferior
view;
S
=
superior
view;
R
=
right;
L
=
left.
P
<
0.005
uncorrected,
threshold
=
25
voxels.
L
=
left.
No
significant
correlation
between
aggressive
phenotype
and
rCBF
was
found.
These
findings
provide
evidence
that
specific
neuroanatomical-
behavioural
relationships
can
be
delineated
in
bvFTD
patients.
Some
studies
have
investigated
the
neuronal
correlates
of
individ-
ual
behavioural
disturbances
in
bvFTD
[18–20]
by
using
different
carer
questionnaire,
with
some
discrepancies.
The
contrasting
results
might
be
partially
due
to
the
selection
of
individual
items
instead
of
behavioural
clusters
that
may
be
not
uniquely
associated
with
brain
damage.
In
fact,
the
utilisation
of
questionnaires,
such
as
Neuropsychiatric
Inventory
or
FBI,
originally
studied
to
discrim-
inate
between
FTD
and
other
types
of
dementia
[21]
do
not
allow
the
detailed
definition
of
different
behavioural
presentations.
At
this
purpose,
confirmatory
factor
analysis
overcomes
the
structural
Table
3
Location
of
the
peaks
of
regional
reduction
of
regional
cerebral
perfusion
in
FTLD
patients
according
to
the
clinical
pattern.
For
aggressive
score
(f3)
none
region
were
statistical
significant
(P
>
0.05).
Region
x
Y
z
T
P
Cluster
size
Disinhibited
score
(f1)
R
superior
temporal
gyrus 46
14
26
5.15
<0.001
1496
R
anterior
cingulate
gyrus
4
20
10
4.63
<0.001
2406
L
orbitofrontal
cortex
0
38
10
4.51
<0.001
L
middle
temporal
gyrus
40
6
34
3.56
<0.001
225
L
inferior
frontal
gyrus
40
28
18
3.02
<0.005
84
Apathetic
score
(f2)
L
superior
frontal
gyrus
20
28
50
3.82
<0.001
1157
R
anterior
cingulate
gyrus
4
22
10
3.30
<0.005
59
L
anterior
cingulate
gyrus
2
16
10
3.12
<0.005
50
Language
score(f4)
L
superior
frontal
gyrus 4
8
66
4.54
<0.001
2178
L
middle
temporal
gyrus
64
22
4
3.86
<0.001
1162
Overall
behavioural
score
(g)
R
inferior
frontal
gyrus
42
22
12
4.20
<0.001
2206
R
insula
48
4
6
4.05
<0.001
R
middle
temporal
gyrus
46
10
30
3.72
<0.001
L
uncus 16
4
24
3.62
<0.001
197
Talairach
coordinates
of
significant
voxels,
at
P
<
0.005
uncorrected.
Threshold
value
=
25.
R:
right
hemisphere;
L:
left
hemisphere.
B.
Borroni
et
al.
/
Behavioural
Brain
Research
235 (2012) 124–
129 129
limit
of
the
FBI
scale,
grouping
functional
correlated
FBI
subitems
without
a
priori
hypothesis.
Prior
studies
have
found
that
patients
with
apathy
showed
dorsolateral
and
medial
frontal
changes,
while
patients
with
disinhibition
had
orbitofrontal
and
temporal
changes
[3,22].
Apathy
has
been
associated
also
with
brain
damage
in
medial
frontal
cortex
and
cingulate
cortex
in
FTD
[23,24],
again
consid-
ered
as
individual
symptom.
Indeed,
if
disinhibition
is
easy
to
detect,
apathy
may
be
associated
and
confounded
with
depressive
symptoms
in
bvFTD
and
more
specific
scales
developed
for
apathy
diagnosis
are
of
help
for
a
better
definition
of
this
symptom.
This
may
further
explain
the
contrasting
results
obtained
on
this
issue.
On
the
other
hand,
disinhibition
is
a
common
behavioural
symp-
tom
in
bvFTD
but
its
neural
correlates
are
still
debated.
A
recent
work
has
evaluated
the
neural
correlates
of
disinhibition
in
a
sam-
ple
of
bvFTD
and
Alzheimer
disease
patients
[18].
As
in
the
present
work,
the
authors
showed
that
this
was
associated
with
damage
of
orbitofrontal
cortex
and
temporal
pole
brain
regions.
Finally,
language
disturbances
are
commonly
detected
in
patients
with
bvFTD
[4],
beyond
being
present
in
the
well-known
temporal
variants
of
FTD,
i.e.
semantic
dementia
and
progressive
non-fluent
aphasia.
Language
deficits
are
frequently
neglected
in
bvFTD,
as
patients
may
be
less
compliant
to
evaluation
because
of
the
present
of
prominent
behavioural
disturbances.
However,
according
to
previous
anatomic
studies
[25],
the
presence
of
lan-
guage
disturbances
in
bvFTD
patients
was
associated
with
greater
damage
in
left
frontotemporal
lobe.
Unlike
the
other
behaviours
included
in
the
analysis,
aggressive
cluster
was
not
uniquely
associated
with
any
specific
brain
region.
From
a
statistical
point
of
view,
this
indicates
that
this
cluster
was
associated
with
a
variance
of
hypoperfusion
common
to
the
other
three
behaviours.
Taking
all
these
findings
into
account,
it
would
appear
that
behavioural
severity
is
associated
with
brain
damage
of
right
frontal
regions,
but
specific
and
distinct
neuronal
networks
in
the
different
phenotypes
may
be
identified.
Indeed,
a
more
strin-
gent
statistical
threshold
for
imaging
analysis
should
be
used
to
have
more
confidence
in
the
findings.
Moreover,
these
results
suggest
that
carer-based
scales
are
helpful
in
carefully
describ-
ing
behavioural
disturbances
in
bvFTD
patients,
even
though
we
acknowledge
that
we
used
a
carer-based
questionnaire
with
the
inherent
problems
of
employing
subjective
information.
From
this
perspective,
the
utilisation
of
a
factor
analysis
modelling
encom-
passes
the
intrinsic
variability
of
such
carer-based
tools,
grouping
the
single
disturbances
in
high-level
clusters,
that
gives
a
more
reli-
able
description
of
the
behavioural
disturbances
in
bvFTD
patients.
In
a
still
orphan
disease,
the
careful
focus
on
the
link
between
complex
behavioural
patterns
and
anatomical
brain
regions
could
be
of
help,
especially
at
the
disease
onset,
to
trace
the
clinical
course
and
in
the
choice
of
the
better
symptomatic
pharmacological
treat-
ment
[26].
The
strengths
of
this
study
were
the
large
sample
size
prospec-
tively
recruited
and
evaluated
by
a
tertiary
referral
centre,
the
standardised
assessment,
and
the
multiple
different
types
of
sta-
tistical
analyses
performed.
Future
confirmatory
studies
are
warranted
and
the
associa-
tion
between
neuropathological
features
and
obtained
behavioural
phenotypes
will
be
of
interest.
References
[1] Hodges
JR.
Frontotemporal
dementia
(Pick’s
disease):
clinical
features
and
assessment.
Neurology
2001;56(11
Suppl.
4):S6–10.
[2]
Snowden
JS,
Neary
D,
Mann
DM.
Frontotemporal
dementia.
British
Journal
of
Psychiatry
2002;180:140–3.
[3]
Le
B,
Guedj
I,
Gabelle
E,
Verpillat
A,
Volteau
P,
Thomas-Anterion
M,
et
al.
Demographic,
neurological
and
behavioural
characteristics
and
brain
perfu-
sion
SPECT
in
frontal
variant
of
frontotemporal
dementia.
Brain
2006;129(Pt
11):3051–65.
[4]
Blair
M,
Marczinski
CA,
Davis-Faroque
N,
Kertesz
A.
A
longitudinal
study
of
language
decline
in
Alzheimer’s
disease
and
frontotemporal
dementia.
Journal
of
the
International
Neuropsychological
Society
2007;13(2):237–45.
[5] Wicklund
AH,
Rademaker
A,
Johnson
N,
Weitner
BB,
Weintraub
S.
Rate
of
cognitive
change
measured
by
neuropsychologic
test
performance
in
3
distinct
dementia
syndromes.
Alzheimer
Disease
and
Associated
Disorders
2007;21(4):S70–8.
[6] Kertesz
A,
Nadkarni
N,
Davidson
W,
Thomas
AW.
The
frontal
behavioral
inven-
tory
in
the
differential
diagnosis
of
frontotemporal
dementia.
Journal
of
the
International
Neuropsychological
Society
2000;6(4):460–8.
[7]
Alberici
A,
Geroldi
C,
Cotelli
M,
Adorni
A,
Calabria
M,
Rossi
G,
et
al.
The
frontal
behavioural
inventory
(Italian
version)
differentiates
frontotemporal
lobar
degeneration
variants
from
Alzheimer’s
disease.
Neurological
Sciences
2007;28(2):80–6.
[8]
McMurtray
AM,
Chen
AK,
Shapira
JS,
Chow
TW,
Mishkin
F,
Miller
BL,
et
al.
Vari-
ations
in
regional
SPECT
hypoperfusion
and
clinical
features
in
frontotemporal
dementia.
Neurology
2006;66(4):517–22.
[9] Neary
D,
Snowden
JS,
Gustafson
L,
Passant
U,
Stuss
D,
Black
S,
et
al.
Frontotem-
poral
lobar
degeneration:
a
consensus
on
clinical
diagnostic
criteria.
Neurology
1998;51(6):1546–54.
[10]
Rascovsky
K,
Hodges
JR,
Knopman
D,
Mendez
MF,
Kramer
JH,
Neuhaus
J,
et
al.
Sensitivity
of
revised
diagnostic
criteria
for
the
behavioural
variant
of
fron-
totemporal
dementia.
Brain
2011;134(Pt
9):2456–77.
[11]
Borroni
B,
Agosti
C,
Premi
E,
Cerini
C,
Cosseddu
M,
Paghera
B,
et
al.
The
FTLD-
modified
clinical
dementia
rating
scale
is
a
reliable
tool
for
defining
disease
severity
in
frontotemporal
lobar
degeneration:
evidence
from
a
brain
SPECT
study.
European
Journal
of
Neurology
2010;17(5):703–7.
[12]
Stokholm
J,
Vogel
A,
Gade
A,
Waldemar
G.
The
executive
interview
as
a
screen-
ing
test
for
executive
dysfunction
in
patients
with
mild
dementia.
Journal
of
the
American
Geriatrics
Society
2005;53(9):1577–81.
[13]
McDonald
RP.
Test
Theory:
A
Unified
Treatment.
New
Jersey:
LEA,
Mahwah;
1999.
[14]
Chen
FF,
West
SG,
Sousa
KH.
A
comparison
of
bifactor
and
second-order
models
of
quality
of
life.
Multivariate
Behavioural
Research
2006;41:189–
225.
[15]
Whitwell
JL,
Przybelski
SA,
Weigand
SD,
Ivnik
RJ,
Vemuri
P,
Gunter
JL,
et
al.
Distinct
anatomical
subtypes
of
the
behavioural
variant
of
frontotemporal
dementia:
a
cluster
analysis
study.
Brain
2009;132(Pt
11):2932–46.
[16] Perri
R,
Koch
G,
Carlesimo
GA,
Serra
L,
Fadda
L,
Pasqualetti
P,
et
al.
Alzheimer’s
disease
and
frontal
variant
of
frontotemporal
dementia
a
very
brief
battery
for
cognitive
and
behavioural
distinction.
Journal
of
Neurology
2005;252(10):1238–44.
[17] Rosen
HJ,
Narvaez
JM,
Hallam
B,
Kramer
JH,
Wyss-Coray
C,
Gearhart
R,
et
al.
Neuropsychological
and
functional
measures
of
severity
in
Alzheimer
dis-
ease,
frontotemporal
dementia,
and
semantic
dementia.
Alzheimer
Disease
and
Associated
Disorders
2004;18(4):202–7.
[18] Hornberger
M,
Geng
J,
Hodges
JR.
Convergent
grey
and
white
matter
evidence
of
orbitofrontal
cortex
changes
related
to
disinhibition
in
behavioural
variant
frontotemporal
dementia.
Brain
2011;134(Pt
9):2502–12.
[19]
Peters
F,
Perani
D,
Herholz
K,
Holthoff
V,
Beuthien-Baumann
B,
Sorbi
S,
et
al.
Orbitofrontal
dysfunction
related
to
both
apathy
and
disinhibition
in
frontotemporal
dementia.
Dementia
and
Geriatric
Cognitive
Disorders
2006;21(5–6):373–9.
[20]
Schroeter
ML,
Vogt
B,
Frisch
S,
Becker
G,
Seese
A,
Barthel
H,
et
al.
Dissociating
behavioral
disorders
in
early
dementia
an
FDG-PET
study.
Psychiatry
Research
2011;194(3):235–44.
[21]
Milan
G,
Lamenza
F,
Iavarone
A,
Galeone
F,
Lore
E,
de
FC,
et
al.
Frontal
behavioural
inventory
in
the
differential
diagnosis
of
dementia.
Acta
Neuro-
logica
Scandinavica
2008;117(4):260–5.
[22]
Massimo
L,
Powers
C,
Moore
P,
Vesely
L,
Avants
B,
Gee
J,
et
al.
Neuroanatomy
of
apathy
and
disinhibition
in
frontotemporal
lobar
degeneration.
Dementia
and
Geriatric
Cognitive
Disorders
2009;27(1):96–104.
[23]
Sarazin
M,
Michon
A,
Pillon
B,
Samson
Y,
Canuto
A,
Gold
G,
et
al.
Metabolic
correlates
of
behavioral
and
affective
disturbances
in
frontal
lobe
pathologies.
Journal
of
Neurology
2003;250(7):827–33.
[24]
Rosen
HJ,
Perry
RJ,
Murphy
J,
Kramer
JH,
Mychack
P,
Schuff
N,
et
al.
Emo-
tion
comprehension
in
the
temporal
variant
of
frontotemporal
dementia.
Brain
2002;125(Pt
10):2286–95.
[25]
Chapman
SB,
Bonte
FJ,
Wong
SB,
Zientz
JN,
Hynan
LS,
Harris
TS,
et
al.
Convergence
of
connected
language
and
SPECT
in
variants
of
frontotem-
poral
lobar
degeneration.
Alzheimer
Disease
and
Associated
Disorders
2005;19(4):202–13.
[26]
Jicha
GA,
Nelson
PT.
Management
of
frontotemporal
dementia:
target-
ing
symptom
management
in
such
a
heterogeneous
disease
requires
a
wide
range
of
therapeutic
options.
Neurodegenerative
Disease
Management
2011;1(2):141–56.
... Using FBI scores and statistical modeling, Borroni et al. (2012) identified four behavioral subgroups in participants with bvFTD, namely "disinhibited, " "apathic, " "language, " and "aggressive." Furthermore, Premi et al. (2013) proposed the behavioral reserve (BR) hypothesis in FTD with cerebral single-photon emission computed tomography (SPECT); this is similar to the concepts of CR in AD and of MR in PD. ...
... The positive and negative behavioral score was calculated by subtracting the FBI score of the positive items or the FBI score of the negative items from the maximum score (36 points); retrospectively, a lower score indicated severe symptoms. The FBI symptoms were categorized into the following four phenotypes (Borroni et al., 2012): (1) disinhibited phenotype (which comprised loss of insight, obsession, hoarding, excessive jocularity, impulsivity, restlessness, hyperorality, and utilization behavior), (2) apathetic phenotype (which comprised apathy and aspontaneity), (3) aggressive phenotype (which comprised inflexibility, irritability, and aggression), and (4) language phenotype (which comprised logopenia, aphasia, comprehensive deficit, and alien hand). We explored the correlations between the scores of each phenotype and the neuroimaging abnormalities. ...
... In previous studies, only in cases with the disinhibited phenotype of bvFTD (which mostly consisted of the FBI score for positive symptoms), correlations between the education level and hypoperfusion in the frontotemporal area were observed on SPECT. However, apathic and language phenotypes, which were a part of the negative symptoms in the FBI, showed no correlated areas (Borroni et al., 2012;Maiovis et al., 2018). Our results were consistent with those of previous studies, suggesting that the education level may not be associated with BR. ...
Article
Full-text available
“Reserve” refers to the individual clinical differences in response to a neuropathological burden. We explored the behavioral reserve (BR) and associated neural substrates in 40 participants with behavioral variant frontotemporal dementia (bvFTD) who were assessed with the frontal behavioral inventory (FBI) and magnetic resonance imaging. Because neuroimaging abnormality showed a high negative correlation with the FBI negative (but not positive) symptom scores, we developed a linear model only to calculate the nBR (BR for negative symptoms) marker using neuroimaging abnormalities and the FBI score. Participants were divided into high nBR and low nBR groups based on the nBR marker. The FBI negative symptom score was lower in the high nBR group than in the low nBR group having the same neuroimaging abnormalities. However, the high nBR group noted a steeper decline in cortical atrophy and showed less atrophy in the left frontotemporal cortices than the low nBR group. In addition, the fractional anisotropy (FA) values were greater in the high nBR than in the low nBR group, except in the sensory-motor and occipital areas. We identified an nBR-related functional network composed of bilateral frontotemporal areas and the left occipital pole. We propose the concept of BR in bvFTD, and these findings can help predict the disease progression.
... For example, our neural correlates of Behavioural changes, Initiation and Executive functions resonate with a large body of work implicating bilateral fronto-insular and striatal regions in the origin of these disturbances in FTD. [54][55][56][57][58][59][60] In contrast, Semantic disturbances, as expected, were associated with bilateral temporopolar, ATL and posterior portions of the ATL bordering posterior temporal/inferior parietal regions. Bilateral ATLs form trans-modal hubs of semantic processing in the brain, 6 the earliest sites of metabolic and structural changes in SD, 61 with atrophy progressing along the ATL correlating with increasing semantic impairment in FTD. ...
Article
Full-text available
Two common clinical variants of frontotemporal dementia are the behavioural variant frontotemporal dementia presenting with behavioural and personality changes attributable to prefrontal atrophy, and semantic dementia displaying early semantic dysfunction primarily due to anterior temporal degeneration. Despite representing independent diagnostic entities, mounting evidence indicates overlapping cognitive-behavioural profiles in these syndromes, particularly with disease progression. Why such overlap occurs remains unclear. Understanding the nature of this overlap, however, is essential to improve early diagnosis, characterisation, and management of those affected. Here, we explored common cognitive-behavioural and neural mechanisms contributing to heterogeneous frontotemporal dementia presentations, irrespective of clinical diagnosis. This transdiagnostic approach allowed us to ascertain whether symptoms not currently considered core to these two syndromes are present in a significant proportion of cases and explore the neural basis of clinical heterogeneity. Sixty-two frontotemporal dementia patients (31 behavioural variant frontotemporal dementia, 31 semantic dementia) underwent comprehensive neuropsychological, behavioural, and structural neuroimaging assessments. Orthogonally-rotated principal component analysis of neuropsychological and behavioural data uncovered eight statistically independent factors explaining the majority of cognitive-behavioural performance variation in behavioural variant frontotemporal dementia and semantic dementia. These factors included Behavioural changes, Semantic dysfunction, General Cognition, Executive function, Initiation, Disinhibition, Visuospatial function, and Affective changes. Marked individual-level overlap between behavioural variant frontotemporal dementia and semantic dementia was evident on the Behavioural changes, General Cognition, Initiation, Disinhibition, and Affective changes factors. Compared to behavioural variant frontotemporal dementia, semantic dementia patients displayed disproportionate impairment on the Semantic dysfunction factor, whereas greater impairment on Executive and Visuospatial function factors was noted in behavioural variant frontotemporal dementia. Both patient groups showed comparable magnitude of atrophy to frontal regions, whereas severe temporal lobe atrophy was characteristic of semantic dementia. Whole-brain voxel-based morphometry correlations with emergent factors revealed associations between fronto-insular and striatal grey matter changes with Behavioural, Executive, and Initiation factor performance, bilateral temporal atrophy with Semantic dysfunction factor scores, parietal-subcortical regions with General Cognitive performance, and ventral temporal atrophy associated with Visuospatial factor scores. Together, these findings indicate that cognitive-behavioural overlap (i) occurs systematically in frontotemporal dementia, (ii) varies in a graded manner between individuals, and (iii) is associated with degeneration of different neural systems. Our findings suggest that phenotypic heterogeneity in frontotemporal dementia syndromes can be captured along continuous, multidimensional spectra of cognitive-behavioural changes. This has implications for the diagnosis of both syndromes amidst overlapping features as well as the design of symptomatic treatments applicable to multiple syndromes.
... A close informant completed the revised Cambridge Behavioural Inventory (CBI-R) [62] and Frontotemporal Dementia Rating Scale (FRS) [63]. To derive each patient's disinhibition phenotype score, we calculated a composite score from the following CBI-R subscales [31,64]: abnormal behaviour, stereotypic movement and behaviour and eating. ...
Article
Full-text available
There is a pressing need to accelerate therapeutic strategies against the syndromes caused by frontotemporal lobar degeneration, including symptomatic treatments. One approach is for experimental medicine, coupling neurophysiological studies of the mechanisms of disease with pharmacological interventions aimed at restoring neurochemical deficits. Here we consider the role of glutamatergic deficits and their potential as targets for treatment. We performed a double-blind placebo-controlled crossover pharmaco-magnetoencephalography study in 20 people with symptomatic frontotemporal lobar degeneration (10 behavioural variant frontotemporal dementia, 10 progressive supranuclear palsy) and 19 healthy age- and gender-matched controls. Both magnetoencephalography sessions recorded a roving auditory oddball paradigm: on placebo or following 10 mg memantine, an uncompetitive NMDA-receptor antagonist. Ultra-high-field magnetic resonance spectroscopy confirmed lower concentrations of GABA in the right inferior frontal gyrus of people with frontotemporal lobar degeneration. While memantine showed a subtle effect on early-auditory processing in patients, there was no significant main effect of memantine on the magnitude of the mismatch negativity (MMN) response in the right frontotemporal cortex in patients or controls. However, the change in the right auditory cortex MMN response to memantine (vs. placebo) in patients correlated with individuals’ prefrontal GABA concentration. There was no moderating effect of glutamate concentration or cortical atrophy. This proof-of-concept study demonstrates the potential for baseline dependency in the pharmacological restoration of neurotransmitter deficits to influence cognitive neurophysiology in neurodegenerative disease. With changes to multiple neurotransmitters in frontotemporal lobar degeneration, we suggest that individuals’ balance of excitation and inhibition may determine drug efficacy, with implications for drug selection and patient stratification in future clinical trials.
... This result supports the presence of a phenotypical heterogeneity in the clinical presentation of bvFTD patients that may reflect specific structural or functional endophenotypes within a syndrome continuum [25,47]. Heterogeneity in behavioral alterations in FTD has been linked to predominant neurodegeneration in temporal or frontal regions [46,48,49], asymmetry in hemispheric involvement [50], or differential genetic susceptibility [51]. In addition, predominant functional metabolic and serotoninergic network vulnerability in prefrontal cortices or limbic structures should be specifically responsible of a differential distribution of the behavioral disorders, as previously proved [52]. ...
Article
Background: The Frontal Behavioral Inventory (FBI) is a questionnaire designed to quantify behavioral changes in frontotemporal dementia (FTD). Literature showed heterogeneous FBI profiles in FTD versus Alzheimer's disease (AD) with variable occurrence of positive and negative symptoms. Objective: In this study, we constructed a short FBI version (i.e., mini-FBI) with the aim to provide clinicians with a short tool for the identification of early behavioral changes in behavioral variant of FTD (bvFTD), also facilitating the differential diagnosis with AD. Methods: 40 bvFTD and 33 AD patients were enrolled. FBI items were selected based on internal consistency and exploratory factor analysis. Convergent validity of mini-FBI was also assessed. A behavioral index (i.e., B-index) representing the balance between positive and negative mini-FBI symptoms was computed in order to analyze its distribution in bvFTD through a cluster analysis and to compare performance among patient groups. Results: The final version of the mini-FBI included 12 items, showing a significant convergent validity with the Neuropsychiatric Inventory scores (rp = 0.61, p < 0.001). Cluster analysis split patients in four clusters. bvFTD were included in three different clusters characterized by prevalent positive symptoms, both positive and negative symptoms, or prevalent negative behavioral alterations, similar to a subset of AD patients. A fourth cluster included only AD patients showing no positive symptoms. Conclusion: The mini-FBI is a valuable easily administrable questionnaire able to early identify symptoms effectively contributing to the bvFTD behavioral syndrome, aiding clinician in diagnosis and management.
... 8,115,164,165 This pattern was also reported in studies that used PET 166 and SPECT. 167 In their study of resting state functional MRI connectivity, Farb et al. 168 found that hyperconnectivity of an executive control network (that included the rostral ACC and anterior insula) to the mPFC was associated with apathy. They also found associations with apathy and connectivity of the mPFC within the salience network and the right angular gyrus within the DMN, and an association between left insula connectivity within the SN and disinhibition. ...
Article
Apathy and disinhibition are common and highly distressing neuropsychiatric symptoms associated with negative outcomes in persons with dementia. This paper is a critical review of functional and structural neuroimaging studies of these symptoms transdiagnostically in dementia of the Alzheimer type, which is characterized by prominent amnesia early in the disease course, and behavioral variant frontotemporal dementia, characterized by early social-comportmental deficits. We describe the prevalence and clinical correlates of these symptoms and describe methodological issues, including difficulties with symptom definition and different measurement instruments. We highlight the heterogeneity of findings, noting however, a striking similarity of the set of brain regions implicated across clinical diagnoses and symptoms. These regions involve several key nodes of the salience network, and we describe the functions and anatomical connectivity of these brain areas, as well as present a new theoretical account of disinhibition in dementia. Future avenues for research are discussed, including the importance of transdiagnostic studies, measuring subdomains of apathy and disinhibition, and examining different units of analysis for deepening our understanding of the networks and mechanisms underlying these extremely distressing symptoms.
... Clinically there are two major forms of FTD, termed behavioral variant (bhv)-FTD and primary progressive aphasia (PPA)-FTD, which is further divided into semantic (sv)-FTD and non-fluent (nfv)-FTD (Liu et al., 2019). These three variants of FTD show different symptoms that are associated with neurodegeneration in distinct regions of the brain ( Table 1; Borroni et al., 2012;Liu et al., 2019). Notably, FTD and amyotrophic lateral sclerosis (ALS) are considered to be neurodegenerative diseases lying on one spectrum, sharing pathological and genetic characteristics, with nearly 50% of ALS patients co-presenting with FTD (Lomen-Hoerth et al., 2003;Ling et al., 2013). ...
Article
Full-text available
Frontotemporal dementia (FTD), hallmarked by antero-temporal degeneration in the human brain, is the second most common early onset dementia. FTD is a diverse disease with three main clinical presentations, four different identified proteinopathies and many disease-associated genes. The exact pathophysiology of FTD remains to be elucidated. One common characteristic all forms of FTD share is the dysregulation of glucose metabolism in patients’ brains. The brain consumes around 20% of the body’s energy supply and predominantly utilizes glucose as a fuel. Glucose metabolism dysregulation could therefore be extremely detrimental for neuronal health. Research into the association between glucose metabolism and dementias has recently gained interest in Alzheimer’s disease. FTD also presents with glucose metabolism dysregulation, however, this remains largely an unexplored area. A better understanding of the link between FTD and glucose metabolism may yield further insight into FTD pathophysiology and aid the development of novel therapeutics. Here we review our current understanding of FTD and glucose metabolism in the brain and discuss the evidence of impaired glucose metabolism in FTD. Lastly, we review research potentially suggesting a causal relationship between FTD proteinopathies and impaired glucose metabolism in FTD.
... Se han descrito deficiencias en la denominación por confrontación 37-39 , la comprensión de palabras aisladas 40 y frases 41 y las habilidades semánticas 41,42 . Por otro lado, la atrofia frontotemporal frecuentemente se superpone con la alteración de las redes neurales del lenguaje 43,44 , y la evidencia neuroanatómica disponible ha relacionado las alteraciones de los circuitos frontales, temporales y parietales con la génesis de las deficiencias del lenguaje de este síndrome 21,36 . De esta manera, el deterioro de las redes corticales que median el procesamiento verbal semántico puede explicar el perfil lingüístico de los pacientes con DFTvC 21 24 , y recientemente el MINT detectó deficiencias en la denominación a diferentes grados de deterioro cognitivo en pacientes con deterioro cognitivo leve y demencia por EA, pero se requiere corregir por edad, sexo, raza y nivel educativo 45 . ...
Article
Introduction Although the absence of memory impairment was considered among the diagnostic criteria to differentiate Alzheimer’s disease (AD) from Behavioural Variant of Frontotemporal Dementia (bvFTD), current and growing evidence indicates that a significant percentage of cases of bvFTD present with episodic memory deficits. In order to compare the performance profile of the naming capacity and episodic memory in patients with AD and bvFTD the present study was designed. Methods Cross-sectional and analytical study with control group (32 people). The study included 42 people with probable AD and 22 with probable bvFTD, all over 60 years old. Uniform Data Set instruments validated in Spanish were used: Multilingual Naming Test (MINT), Craft-21 history and Benson’s complex figure, among others. Results A higher average age was observed among the patients with AD. The naming capacity was much lower in patients with bvFTD compared to patients with AD, measured according to the MINT and the nouns/verbs naming coefficient. All patients with bvFTD, 73.81% of those with AD and only 31.25% of the control group failed to recognise Benson’s complex figure. All differences were statistically significant (p < 0.001). Results This study confirms the amnesic profile of patients with AD and reveals the decrease in naming capacity in patients with bvFTD, an area of language that is typically affected early on with executive functions, according to recent findings. Conclusions Patients with AD perform worse in verbal and visual episodic memory tasks, while patients with bvFTD perform worse in naming tasks. These findings open the possibility of exploring the mechanisms of prefrontal participation in episodic memory, typically attributed to the hippocampus.
Preprint
Full-text available
Neurodegenerative dementias have a profound impact on higher-order cognitive and behavioural functions. Investigating macroscale functional networks through cortical gradients provides valuable insights into the neurodegenerative dementia process and overall brain function. This approach allows for the exploration of unimodal-multimodal differentiation and the intricate interplay between functional brain networks. We applied cortical gradients mapping in frontotemporal dementia (FTD) patients (behavioural-bvFTD, non-fluent and semantic) and healthy controls. In healthy controls, two principal gradients maximally distinguished sensorimotor from default-mode network (DMN) and visual from salience network (SN). However, in bvFTD, this unimodal-multimodal differentiation was disrupted, impacting the interaction among all networks. Importantly, these disruptions extended beyond the observed atrophy distribution. Semantic and non-fluent variants exhibited more focal alterations in limbic and sensorimotor networks, respectively. The DMN and visual networks demonstrated contrasting correlations with social cognition performances, suggesting either early damage (DMN) or compensatory processes (visual). In conclusion, optimal brain function requires networks to operate in a segregated yet collaborative manner. In FTD, our findings indicate a collapse and loss of differentiation between networks that goes beyond the observed atrophy distribution. These specific cortical gradients’ fingerprints could serve as a novel biomarker for identifying early changes in neurodegenerative diseases or potential compensatory processes.
Article
The selective vulnerability of brain networks in individuals at risk for Alzheimer's disease (AD) may help differentiate pathological from normal aging at asymptomatic stages, allowing the implementation of more effective interventions. We used a sample of 72 people across the age span, enriched for the APOE4 genotype to reveal vulnerable networks associated with a composite AD risk factor including age, genotype, and sex. Sparse canonical correlation analysis (CCA) revealed a high weight associated with genotype, and subgraphs involving the cuneus, temporal, cingulate cortices, and cerebellum. Adding cognitive metrics to the risk factor revealed the highest cumulative degree of connectivity for the pericalcarine cortex, insula, banks of the superior sulcus, and the cerebellum. To enable scaling up our approach, we extended tensor network principal component analysis, introducing CCA components. We developed sparse regression predictive models with errors of 17% for genotype, 24% for family risk factor for AD, and 5 years for age. Age prediction in groups including cognitively impaired subjects revealed regions not found using only normal subjects, i.e. middle and transverse temporal, paracentral and superior banks of temporal sulcus, as well as the amygdala and parahippocampal gyrus. These modeling approaches represent stepping stones towards single subject prediction.
Article
Full-text available
Disinhibition is a common behavioural symptom in frontotemporal dementia but its neural correlates are still debated. In the current study, we investigated the grey and white matter neural correlates of disinhibition in a sample of behavioural variant frontotemporal dementia (n = 14) and patients with Alzheimer's disease (n = 15). We employed an objective (Hayling Test of inhibitory functioning) and subjective/carer-based (Neuropsychiatric Inventory) measure of disinhibition to reveal convergent evidence of disinhibitory behaviour. Mean and overlap-based statistical analyses were conducted to investigate profiles of performance in patients with behavioural variant frontotemporal dementia, Alzheimer's disease and controls. Hayling Test and Neuropsychiatric Inventory scores were entered as covariates in a grey matter voxel-based morphometry, as well as in a white matter diffusion tensor imaging analysis to determine the underlying grey and white matter correlates. Patients with behavioural variant frontotemporal dementia showed more disinhibition on both behavioural measures in comparison to patients with Alzheimer's disease and controls. Voxel-based morphometry results revealed that atrophy in orbitofrontal/subgenual, medial prefrontal cortex and anterior temporal lobe areas covaried with total errors score of the Hayling Test. Similarly, the Neuropsychiatric Inventory disinhibition frequency score correlated with atrophy in orbitofrontal cortex and temporal pole brain regions. The orbitofrontal atrophy related to the objective (Hayling Test) and subjective (Neuropsychiatric Inventory) measures of disinhibition was partially overlapping. Diffusion tensor imaging analysis revealed that white matter integrity fractional anisot-ropy values of the white matter tracts connecting the identified grey matter regions, namely uncinate fasciculus, forceps minor and genu of the corpus callosum, correlated well with the total error score of the Hayling Test. Our results show that a network of orbitofrontal, anterior temporal and mesial frontal brain regions and their connecting white matter tracts are involved in inhibitory functioning. Further, we find convergent evidence for objective and subjective disinhibition measures that the orbito-frontal/subgenual brain region is critical for adapting and maintaining normal behaviour.
Article
Full-text available
Bifactor and second-order factor models are two alternative approaches for repre-senting general constructs comprised of several highly related domains. Bifactor and second-order models were compared using a quality of life data set (N = 403). The bifactor model identified three, rather than the hypothesized four, domain specific factors beyond the general factor. The bifactor model fit the data significantly better than the second-order model. The bifactor model allowed for easier interpretation of the relationship between the domain specific factors and external variables, over and above the general factor. Contrary to the literature, sufficient power existed to distin-guish between bifactor and corresponding second-order models in one actual and one simulated example, given reasonable sample sizes. Advantages of bifactor models over second-order models are discussed. Researchers interested in assessing a construct often hypothesize that several highly related domains comprise the general construct of interest. In the motivat-ing example, which is the focus of this article, Stewart and Ware (1992) proposed measures of health-related quality of life. They hypothesized that this general con-struct was comprised of at least four highly related domain specific factors (cogni-tion, vitality, mental health, and disease worry)., these authors se-lected 17-items to represent the four domains that were hypothesized to comprise the general construct. Other researchers have also hypothesized general constructs MULTIVARIATE BEHAVIORAL RESEARCH, 41(2), 189–225 Copyright © 2006, Lawrence Erlbaum Associates, Inc.
Article
Full-text available
There are no US FDA-approved therapies for the management of frontotemporal dementia (FTD). Evidence-based medicine that would support a FDA indication for the treatment of FTD requires large-scale, randomized, double-blind, placebo-controlled trials that do not currently exist. Progress in obtaining approval and therapeutic indications for FTD has been severely hampered by the heterogeneity of clinical and pathological phenotypes seen in various FTD disease states. These issues are often misinterpreted by clinicians, caregivers and patients suggesting that potential treatment options are nonexistent for this devastating disease. This article discusses these issues in the context of recent studies and publications investigating therapeutic options in FTD, and further suggests a rationale for individualized therapy in FTD. Targeting the myriad of symptoms seen in FTD requires recognition of such symptoms that may play primary or secondary roles in the spectrum of deficits that lead to functional disability in FTD, and the availability of a wide range of therapeutic options that may be helpful in alleviating such symptomatology. Fortunately, agents targeting the many cognitive, behavioral, psychiatric and motor symptoms that can be seen in FTD are readily available, having been previously developed and approved for symptomatic benefit in other disease states. In contrast to the widespread belief that beneficial treatments are not available for FTD today, our therapeutic armament is stocked with pharmacological tools that may improve quality of life for those suffering from this devastating and incurable class of degenerative diseases.
Article
Full-text available
Based on the recent literature and collective experience, an international consortium developed revised guidelines for the diagnosis of behavioural variant frontotemporal dementia. The validation process retrospectively reviewed clinical records and compared the sensitivity of proposed and earlier criteria in a multi-site sample of patients with pathologically verified frontotemporal lobar degeneration. According to the revised criteria, 'possible' behavioural variant frontotemporal dementia requires three of six clinically discriminating features (disinhibition, apathy/inertia, loss of sympathy/empathy, perseverative/compulsive behaviours, hyperorality and dysexecutive neuropsychological profile). 'Probable' behavioural variant frontotemporal dementia adds functional disability and characteristic neuroimaging, while behavioural variant frontotemporal dementia 'with definite frontotemporal lobar degeneration' requires histopathological confirmation or a pathogenic mutation. Sixteen brain banks contributed cases meeting histopathological criteria for frontotemporal lobar degeneration and a clinical diagnosis of behavioural variant frontotemporal dementia, Alzheimer's disease, dementia with Lewy bodies or vascular dementia at presentation. Cases with predominant primary progressive aphasia or extra-pyramidal syndromes were excluded. In these autopsy-confirmed cases, an experienced neurologist or psychiatrist ascertained clinical features necessary for making a diagnosis according to previous and proposed criteria at presentation. Of 137 cases where features were available for both proposed and previously established criteria, 118 (86%) met 'possible' criteria, and 104 (76%) met criteria for 'probable' behavioural variant frontotemporal dementia. In contrast, 72 cases (53%) met previously established criteria for the syndrome (P < 0.001 for comparison with 'possible' and 'probable' criteria). Patients who failed to meet revised criteria were significantly older and most had atypical presentations with marked memory impairment. In conclusion, the revised criteria for behavioural variant frontotemporal dementia improve diagnostic accuracy compared with previously established criteria in a sample with known frontotemporal lobar degeneration. Greater sensitivity of the proposed criteria may reflect the optimized diagnostic features, less restrictive exclusion features and a flexible structure that accommodates different initial clinical presentations. Future studies will be needed to establish the reliability and specificity of these revised diagnostic guidelines.
Article
Based on the recent literature and collective experience, an international consortium developed revised guidelines for the diagnosis of behavioural variant frontotemporal dementia. The validation process retrospectively reviewed clinical records and compared the sensitivity of proposed and earlier criteria in a multi-site sample of patients with pathologically verified frontotemporal lobar degeneration. According to the revised criteria, 'possible' behavioural variant frontotemporal dementia requires three of six clinically discriminating features (disinhibition, apathy/inertia, loss of sympathy/empathy, perseverative/ compulsive behaviours, hyperorality and dysexecutive neuropsychological profile). 'Probable' behavioural variant frontotemporal dementia adds functional disability and characteristic neuroimaging, while behavioural variant frontotemporal dementia 'with definite frontotemporal lobar degeneration' requires histopathological confirmation or a pathogenic mutation. Sixteen brain banks contributed cases meeting histopathological criteria for frontotemporal lobar degeneration and a clinical diagnosis of behavioural variant frontotemporal dementia, Alzheimer's disease, dementia with Lewy bodies or vascular dementia at presentation. Cases with predominant primary progressive aphasia or extra-pyramidal syndromes were excluded. In these autopsy-confirmed cases, an experienced neurologist or psychiatrist ascertained clinical features necessary for making a diagnosis according to previous and proposed criteria at presentation. Of 137 cases where features were available for both proposed and previously established criteria, 118 (86%) met 'possible' criteria, and 104 (76%) met criteria for 'probable' behavioural variant frontotemporal dementia. In contrast, 72 cases (53%) met previously established criteria for the syndrome (P 5 0.001 for comparison with 'possible' and 'probable' criteria). Patients who failed to meet revised criteria were significantly older and most had atypical presentations with marked memory impairment. In conclusion, the revised criteria for behavioural variant fronto-temporal dementia improve diagnostic accuracy compared with previously established criteria in a sample with known fronto-temporal lobar degeneration. Greater sensitivity of the proposed criteria may reflect the optimized diagnostic features, less restrictive exclusion features and a flexible structure that accommodates different initial clinical presentations. Future studies will be needed to establish the reliability and specificity of these revised diagnostic guidelines.
Article
Disinhibition is a common behavioural symptom in frontotemporal dementia but its neural correlates are still debated. In the current study, we investigated the grey and white matter neural correlates of disinhibition in a sample of behavioural variant frontotemporal dementia (n = 14) and patients with Alzheimer's disease (n = 15). We employed an objective (Hayling Test of inhibitory functioning) and subjective/carer-based (Neuropsychiatric Inventory) measure of disinhibition to reveal convergent evidence of disinhibitory behaviour. Mean and overlap-based statistical analyses were conducted to investigate profiles of performance in patients with behavioural variant frontotemporal dementia, Alzheimer's disease and controls. Hayling Test and Neuropsychiatric Inventory scores were entered as covariates in a grey matter voxel-based morphometry, as well as in a white matter diffusion tensor imaging analysis to determine the underlying grey and white matter correlates. Patients with behavioural variant frontotemporal dementia showed more disinhibition on both behavioural measures in comparison to patients with Alzheimer's disease and controls. Voxel-based morphometry results revealed that atrophy in orbitofrontal/subgenual, medial prefrontal cortex and anterior temporal lobe areas covaried with total errors score of the Hayling Test. Similarly, the Neuropsychiatric Inventory disinhibition frequency score correlated with atrophy in orbitofrontal cortex and temporal pole brain regions. The orbitofrontal atrophy related to the objective (Hayling Test) and subjective (Neuropsychiatric Inventory) measures of disinhibition was partially overlapping. Diffusion tensor imaging analysis revealed that white matter integrity fractional anisot-ropy values of the white matter tracts connecting the identified grey matter regions, namely uncinate fasciculus, forceps minor and genu of the corpus callosum, correlated well with the total error score of the Hayling Test. Our results show that a network of orbitofrontal, anterior temporal and mesial frontal brain regions and their connecting white matter tracts are involved in inhibitory functioning. Further, we find convergent evidence for objective and subjective disinhibition measures that the orbito-frontal/subgenual brain region is critical for adapting and maintaining normal behaviour.
Article
Article abstract—The clinical presentation in frontotemporal dementia (FTD) reflects the distribution of the pathologic changes rather than the exact histologic subtype of the disease. Three major clinical syndromes can be identified: 1) frontal variant FTD (dementia of frontal type) in which changes in social behavior and personality predominate, reflecting the orbitobasal frontal lobe focus of the pathology. Traditional cognitive tests are insensitive, but more specific measures are under development; 2) semantic dementia (progressive fluent aphasia) in which there is a breakdown in the conceptual database which underlies language production and comprehension, although deficits in nonverbal semantic knowledge can also be shown on neuropsychologic testing. Patients with semantic dementia have asymmetric anterolateral temporal atrophy with relative sparing of the hippocampal formation, which is typically worse on the left side. A variant of this syndrome affecting the right temporal lobe presents with progressive prosopagnosia; 3) progressive nonfluent aphasia in which the phonologic and syntactic components of language are affected in association with left peri-Sylvian atrophy. The assessment of patients with potential FTD involves a multidisciplinary approach. The development of comprehensive caregiver-based neuropsychiatric instruments, neuropsychologic tasks sensitive to semantic memory and other key cogni-tive impairments, and functional (hexamethyly-propyleneamine-SPECT) and structural (MRI) brain imaging represent significant advances in the field. NEUROLOGY 2001;56(Suppl 4):S6 –S10
Article
Frontotemporal dementia accounts for up to 20% of cases of dementia in the presenium, yet remains poorly recognised. Diagnostic criteria have been devised to aid clinical diagnosis. To provide an overview of clinical and pathological characteristics of frontotemporal dementia and its nosological status. The review summarises consensus diagnostic criteria for frontotemporal dementia and draws on the authors' clinical experience of 300 frontotemporal dementia cases, and pathological experience of 50 autopsied cases. Frontotemporal dementia is characterised by pronounced changes in affect and personal and social conduct. Some patients also develop motor neuron disease. Mutations in the tau gene account for some but not all familial cases of frontotemporal dementia. Frontotemporal dementia is a focal form of dementia, which is clinically and pathologically distinct from other dementias. It represents an important model for understanding the functions of the frontotemporal lobes.
Article
Behavioral impairments occur frequently in dementia. Studies with magnetic resonance imaging, measuring atrophy, have systematically investigated their neural correlates. Such a systematic approach has not yet been applied to imaging with [(18)F] fluorodeoxyglucose positron emission tomography (FDG-PET), although regional hypometabolism may precede and exceed atrophy in dementia. The present study related all behavioral disorders as assessed with the Neuropsychiatric Inventory to reductions in brain glucose utilization as measured by FDG-PET with Statistical Parametric Mapping (SPM5). It included 54 subjects mainly with early Alzheimer's disease, frontotemporal lobar degeneration, and subjective cognitive impairment. Apathy, disinhibition and eating disorders - most frequent in frontotemporal lobar degeneration - correlated significantly with regional brain hypometabolism. Whereas a single regressor analysis and conjunction analysis revealed largely overlapping frontomedian regions that were associated with all three behavioral domains, a disjunction analysis identified three specific neural networks for each behavioral disorder, independent of dementia severity. Apathy was related to the ventral tegmental area, a component of the motivational dopaminergic network; disinhibition to both anterior temporal lobes including the anterior hippocampi and left amygdala, caudate head, orbitofrontal cortex and insulae; and eating disorders to the right lateral (orbito) frontal cortex/insula. Our study contributes to the understanding of behavioral deficits in early dementia and suggests specific diagnostic and therapeutic approaches.